NYSE: EQREquity Residential Stock
$75.24-1.42 (-1.85%)
Updated Dec 2, 2024
EQR Price
$75.24
Fair Value Price
N/A
Market Cap
$28.55B
52 Week Low
$57.33
52 Week High
$78.84
P/E
30.71x
P/B
2.63x
P/S
9.59x
PEG
1.54x
Dividend Yield
3.57%
Revenue
$2.94B
Earnings
$928.41M
Gross Margin
63.6%
Operating Margin
40.94%
Profit Margin
31.5%
Debt to Equity
0.88
Operating Cash Flow
$2B
Beta
0.89
Next Earnings
Jan 28, 2025
Ex-Dividend
N/A
Next Dividend
N/A
EQR Overview
Equity Residential is a real estate investment trust (REIT) that invests in apartments. One of the largest owners of apartments in the U.S., the company owns or has investments in 310 properties (80,407 units) in Southern California, San Francisco, Washington, D.C., New York City, Boston, Seattle, Denver, Atlanta, Dallas/Ft. Worth, and Austin. Equity Residential was founded in 1969 and is headquartered in Chicago, IL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EQR's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Value
F
Growth
C
Momentum
C
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Residential REIT
Industry Rating
F
EQR
Ranked#16 of 19
Ranked#16 of 19
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $16.86 | C | |
| $18.96 | C | |
| $304.09 | C |
Be the first to know about important EQR news, forecast changes, insider trades & much more!
EQR News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EQR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EQR ($75.24) is trading above its intrinsic value of $30.96, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EQR is poor value based on its earnings relative to its share price (30.71x), compared to the US market average (28.28x)
P/E vs Market Valuation
EQR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more EQR due diligence checks available for Premium users.
Valuation
EQR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
30.71x
Industry
26.26x
Market
28.28x
EQR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EQR is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
EQR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.63x
Industry
2.7x
EQR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EQR price to earnings growth (PEG)
For valuing profitable companies with growth potential
EQR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
EQR's financial health
Profit margin
Revenue
$748.3M
Net Income
$143.4M
Profit Margin
19.1%
EQR's Earnings (EBIT) of $1.20B... subscribe to Premium to read more.
Interest Coverage Financials
EQR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$20.9B
Liabilities
$9.5B
Debt to equity
0.88
EQR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EQR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$401.4M
Investing
-$1.4B
Financing
$948.0M
EQR's operating cash flow ($1.56B)... subscribe to Premium to read more.
Debt Coverage Financials
EQR vs Residential REIT Stocks
Equity Residential Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.